【摘要】 目的:探讨生物共振仪治疗儿童支气管哮喘的有效性和复发情况。方法:选取进行生物共振治疗的支气管哮喘患儿55例,随机分为两组(疗程为6月以内组25例和疗程为6月以上组30例)。所有患儿均接受每周一次生物共振治疗,必要时应用治疗性药物如糖皮质激素、白三烯调节剂及β2受体激动剂和茶碱等。治疗前及疗程结束时各测一次呼气峰流速,并观察2年内的复发情况。结果:生物共振仪治疗后,两组患儿的最大呼气流量(PEFR)均明显提高。6月以内组和6月以上组的峰值呼气流速(PEF)变化值分别由(68.00±3.14)%和(69.95±4.74)%上升至(86.92±3.59)%和(91.62±2.84)%。2年内6月以内组患儿有10例复发,复发率为40%;6月以上组患儿有3例复发,复发率为10%。结论:支气管哮喘患儿应尽早进行生物共振与药物联合治疗,以缓解症状降低复发率。更多还原

【Abstract】 Objective: To evaluate efficacy and recurrence of bioresonnance therapy in children with bronchial asthma. Methods: Fifty-five children with asthma by bioresonnance therapy were randomly divided into two groups include within six-month group, and above six-month group according to the course of treatment. All patients received bioresonnance therapy once a week, they used therapeutic medicines include corticosteroids, LTRA, β2-agonists, and theophylline when necessary. The peak expiratory flow rate(PEFR)was measured at the time of pre-treatment and posttreatment, and observed recurrence rate in two years. Results: The PEFR value of the two groups improved evidently post- treatment. The PEFR value of the within six-month group, and the above six-month group rose from 68.00±3.14, 69.95±4.74 to 86.92±3.59, 91.62±2.84.10 patients recurred in the within six-month group, which accounted for 40.00% in two years;3 patients recurred in the above six-month group, which accounted for 10.00% in two years. Conclusion: Children with bronchial asthma should be treated by bioresonance and medicines together as early as possible, which could relieve symptoms and reduce recurrence rate.更多还原